HeartCore Enterprises, Inc. (NASDAQ:HTCR) Announces 1-for-20 Reverse Stock Split

• HeartCore Enterprises, Inc. (NASDAQ:HTCR) will implement a 1-for-20 reverse stock split, effective April 2, 2026 at 4:00 p.m. Eastern Time, primarily to increase its share price and regain compliance with Nasdaq’s $1.00 minimum bid price requirement.
• The company maintains a low debt-to-equity ratio of approximately 0.20–0.25 and a current ratio of 1.40, indicating reasonable short-term liquidity despite ongoing operational challenges.
• With a market capitalization of roughly $4.2 million and high volatility (beta of 1.99), HTCR remains a micro-cap stock facing significant challenges as an unprofitable or marginally profitable IPO consulting firm.

HeartCore Enterprises, Inc. (NASDAQ:HTCR) is a Tokyo-based company specializing in IPO consulting services and related business support in Japan.

On April 1, 2026, the company announced that its Board of Directors approved a 1-for-20 reverse stock split of its issued and outstanding common stock. Stockholders had previously authorized the reverse split on June 30, 2025. The reverse split will become effective on April 2, 2026 at 4:00 p.m. Eastern Time. The company’s common stock is expected to begin trading on a split-adjusted basis under a new CUSIP number 42240Q203 on the Nasdaq Capital Market starting April 6, 2026.

The primary goal of the reverse split is to increase the per-share price to help HeartCore regain compliance with Nasdaq’s minimum bid price listing requirement of $1.00. No change will occur to the company’s authorized share count or par value, and fractional shares will be rounded up to the nearest whole share.

Prior to the split, HTCR shares have been trading well below $1.00, recently in the $0.16–$0.22 range. The 50-day moving average was around $0.25 and the 200-day moving average near $0.48 (these figures will be adjusted proportionally higher post-split). Over the past year, the stock has shown extreme volatility, with a 52-week range between approximately $0.15 and $1.67.

HeartCore’s market capitalization stands at approximately $4.2 million. The company carries a beta of 1.99, indicating significantly higher volatility than the broader market. Weiss Ratings recently reaffirmed a “sell (d-)” rating, reflecting cautious sentiment.

Financial Position Highlights: The company reports a low debt-to-equity ratio of about 0.20, suggesting conservative leverage. Its current ratio and quick ratio both stand near 1.40, pointing to an adequate ability to meet short-term obligations. However, HeartCore has faced revenue declines (full-year 2025 revenue of $9.0 million, down significantly year-over-year) but recorded a net income of $5.5 million for 2025, largely due to a one-time gain from the sale of HeartCore Japan.